lifestyle.thedishh.com

Author: VOLITION DIAGNOSTICS UK LIMITED

VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q® Cancer Assays

January 30, 2026
Volition Announces Data to Support Use of Nu.Q® NETs in New Indication

January 27, 2026
Volition Continues to Extend Access to Nu.Q® Vet Cancer Test

January 20, 2026
Volition Sponsors Symposium at Veterinary Meeting and Expo

January 16, 2026
VolitionRx Secures $2.0 Million in Funding

January 8, 2026
VolitionRx Announces Breakthrough Clinical Data for Nu.Q® Vet Cancer Test in Cats

January 8, 2026
Volition Issues Business Review 2025

December 23, 2025